The case for adding MOTS-c is that retatrutide alone leaves a gap inside the cell
Some evidence suggests GLP-1 drugs may reduce inflammatory signals in the body, including pathways involved in autoimmune disease
A lot of people also think that early hormone exposure always harms the fetus
Ivm partners exclusively with licensed compounding pharmacies that maintain strict quality-control measures and testing programs
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
Tirzepatide is not for normal people who want to become fashionably thin